HPV treatments are unproven, but what do women want?
NCT ID NCT06123533
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
This study interviews women aged 25 to 64 who have a high-risk HPV infection to learn what they value in potential treatments, such as cost, how the treatment is given, and how long it lasts. The researchers want to understand whether women consider unapproved treatments, what benefits and risks matter to them, and how much they might be willing to pay. The goal is to improve conversations between clinicians and patients and to inform future research on HPV management.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- This study could help doctors and patients have better conversations about managing HPV, and guide future research on what treatments women might want.
- What could go wrong
- This is a small interview study with only 9 participants, so its findings may not apply to all women. It does not test any treatment itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
9 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be identified through their cervical screening record on Scottish Cervical Call Recall System (SCCRS) records at the Women's Day Clinic (colposcopy clinic) in NHS Grampian.
- Ages
-
25 to 64 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Non-pregnant, English speaking, female patients aged 25-64 years * Women with cervical high risk HPV infection * Normal colposcopy, or, if cytological or histological changes present at colposcopy, a diagnosis of borderline nuclear abnormalities, low grade dyskaryosis or CIN1 only Exclusion Criteria: * Cytological or histological diagnosis of CIN2+, high grade dyskaryosis, or cervical cancer at colposcopy * Planned treatments that involve surgical excision e.g. LEEP, LLETZ, conisation or ablation of cervix * Chronic immunosuppression * Limited English language proficiency
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Human papilloma virus infection are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aberdeen Centre for Women's Health Research
Aberdeen, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.